KOB-03

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameKOB-03
Drug Alias NameKOB-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-6 inhibitorsP38 γ mitogen-activated protein kinase inhibitorsInterleukin-1 beta inhibitors +[6] 
TargetsP38 γ mitogen-activated protein kinaseNuclear factor NF-kappa-B complexInterleukin-6 +[6] 
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDong Wha Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDong Wha Pharm Co Ltd
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A